Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-κB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages-Reference-Cited by-同舟云学术

Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-κB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages

Published:2018-04-26 Issue: Volume:24 Page:2569-2577
ISSN:1643-3750
Container-title:Medical Science Monitor
language:en
Short-container-title:Med Sci Monit

Author:

Jin Gu¹,Wang Fang-Fang²,Li Tao¹,Jia Dong-Dong¹,Shen Yong³,Xu Hai-Chao¹

Affiliation:

1. Department of Bone and Soft Tissue Surgery, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China (mainland)

2. Department of Gynecologic Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China (mainland)

3. Department of Emergency, Zhejiang Provincial Peoples’ Hospital, Peoples’ Hospital of Hangzhou Medical College, Hangzhou, Zhejiang, China (mainland)

Publisher

International Scientific Information, Inc.

Subject

General Medicine

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neogambogic acid enhances anti-PD-1 immunotherapy efficacy by attenuating suppressive function of MDSCs in pancreatic cancer;International Immunopharmacology;2024-09

2. BML‐111 inhibits osteoclast differentiation by suppressing the MAPK and NF‐κB pathways, alleviating deterioration of the knee joints in a CIA rat model;Cell Biology International;2023-02-05

3. Neogambogic acid relieves myocardial injury induced by sepsis via p38 MAPK/NF-κB pathway;The Korean Journal of Physiology & Pharmacology;2022-11-01

4. Interdependence Between Body Weight, Depth of Inflammation and Functional Capacity of the Pancreas in Patients with Primary Osteoarthritis and Type 2 Diabetes;Family medicine. European practices;2022-10-28

5. How zoledronic acid improves osteoporosis by acting on osteoclasts;Frontiers in Pharmacology;2022-08-25